TICKER - Dog Days Of Alpha Goldman Injects Cash To Shore Up A Big Fund But Faces A Major Drop In Performance Fees
Goldman, Sachs & Co. got a black eye in August when some of its highest-profile hedge funds plunged in value, but the blow may be worse than it first seemed.